Sales & Marketing News | pharmaphorum

News

Lilly trumpets new weight-loss data with Mounjaro

Eli Lilly’s new therapy Mounjaro has aced a second phase 3 trial as a treatment of obesity or being overweight, this time in patients with type 2 diabetes.

News

Changing Faces: Agency, consultancy, and investor hires from...

In March we saw just a handful of hires in the pharma marketing world, including some high-profile appointments.

News

Boerner to lead BMS after CEO Caforio steps down

Bristol-Myers Squibb’s long-serving chief executive Giovanni Caforio has said he will retire on 1st November after almost eight years in the role and more than two decades

News

Single market at heart of EU plans for pharma reform

The European Commission’s long-promised revamp of pharmaceutical legislation is finally unveiled, and it’s ambitious to say the least.

News

Shingrix helps GSK make a solid start in 2023

GSK managed to beat analysts’ revenue predictions for the first quarter of the year, despite an 8% decline in turnover pegged back by declines in COVID-19-related products

News

Changing Faces: Biopharma hires from March 2023

March wasn’t the busiest month for big pharma shakeups, especially compared to the start of the year, but there was plenty of hustle and bustle at smaller pharma and biotech firms.

Lilly trumpets new weight-loss data with Mounjaro

Changing Faces: Agency, consultancy, and investor hires from...

Boerner to lead BMS after CEO Caforio steps down

Single market at heart of EU plans for pharma reform

Shingrix helps GSK make a solid start in 2023

Changing Faces: Biopharma hires from March 2023

Pfizer cues up vitiligo filing for Litfulo after phase 3 win

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks